Medical prophylaxis of haemorrhage from oesophageal varices in patients with liver cirrhosis

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 6, 1997, Pages 603-612

  Gross, Manfred ^a   Zoller, Wolfram G ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Beta adrenergic blockers; Gastrointestinal bleeding; Hepatic cirrhosis; Oesophageal varices; Prophylaxis; Sclerotherapy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES BLEEDING; HIGH RISK PATIENT; HUMAN; LIGATION; LIVER CIRRHOSIS; MORTALITY; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; SCORING SYSTEM;

EID: 0030918962     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199706000-00010     Document Type: Review

References (95)

1. Burroughs AK, D'Heygere F, McIntyre N: Pitfalls in studies of prophylactic therapy for variceal bleeding in cirrhotics. Hepatology 1986, 6:1407-1413.
2. Graham DY, Smith JL: The course of patients after variceal hemorrhage. Gastroenterology 1981, 80:800-809.
3. Pascal J-P: Non-surgical treatment of hemorrhage caused by portal hypertension in cirrhosis: hemostatic treatment, prevention of the first hemorrhage, prevention of recurrence. Rev Prat 1990, 40:1458-1461.
4. Sieg A, Kommerell B: Primäre Prophylaxe der Ösophagusvarizenblutung durch β-Blockade - allgemein indiziert? Klin Wochenschr 1988, 66:1099-1101.
5. Zoller WG, Gross M: Drug treatment of esophageal variceal bleeding: alternative or supplement to endoscopic therapy? Endoscopy 1995, 27:616-621.
6. Colombo M, De Franchis R, Tommasini M, et al.: β-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial. Hepatology 1989, 9:433-438.
7. Macdougall BR, Westaby D, Theodossi A, et al.: Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Lancet 1982, i:124-127.
8. The Copenhagen Esophageal Varices Sclerotherapy Project: Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. N Engl J Med 1984, 311:1594-1600.
9. The PROVA Study Group: Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: a randomized multicenter trial. Hepatology 1991, 14:1016-1024.
10. Groszmann RJ, Bosch J, Grace ND, et al.: Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990, 99:1401-1407.
11. Lebrec D: Drugs for portal hypertension. J Gastroenterol Hepatol 1987, 2:361-374.
12. Lebrec D: Pharmacologic prevention of variceal bleeding and rebleeding. J Hepatol 1993, 17(suppl. 2):29-33.
13. Lebrec D, Nouel O, Corbic M, et al.: Propranolol - a medical treatment for portal hypertension? Lancet 1980, ii:180-182.
14. Bendtsen F, Henriksen JH, Sørensen TIA: Propranolol and haemodynamic response in cirrhose. J Hepatol 1991, 13:144-148.
15. Okano H, Tsuji J, Kodama T, et al.: Effect of endoscopic sclerotherapy and propranolol on the blood flow of esophageal varices. Am J Gastroenterol 1990, 85:30-33.
16. Zoller WG, Zentner J, Middeke M: Duplexsonographische Untersuchungen zur Hämodynamik des Pfortadersystems unter Beta-Blockade bei Patienten mit Leberzirrhose. In Ultraschalldiagnostik 90. Edited by Walser G, Haselbach H, Brandtner W. Berlin, Heidelberg: Springer Verlag; 1991:135-139.
17. Feu F, Bordas JM, Garcia-Pagán JC, et al.: Double-blind investigation of the effects of propranolol and placebo on the pressure of esophageal varices in patients with portal hypertension. Hepatology 1991, 13:917-922.
18. Aramaki T, Sekiyama T, Katsuta Y, et al.: Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new β-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol. J Hepatol 1992, 15:48-53.
19. Freeman JG, Barton JG, Record CO: Effect of isosorbide dinitrate, verapamil and labetalol on portal pressure in cirrhosis. BMJ 1985, 291:561-562.
20. Mastai R, Bosch J, Bruix J, et al.: β-Blockade with propranolol and hepatic artery blood flow in patients with cirrhosis. Hepatology 1989, 10:269-272.
21. Bendtsen F, Henriksen JH, Sørensen TIA: Long-term effects of oral propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis and oesophageal varices. Scand J Gastroenterol 1991, 26:933-939.
22. Zoller WG, Wagner DR, Zentner J: Effect of propranolol on portal vein hemodynamics: assessment by duplex sonography and indocyanine green clearance in healthy volunteers. Clin Invest 1993, 71:654-658.
23. Zoller WG, Wagner DR, Zentner J: Effect of propranolol on portal vein hemodynamics in patients with liver cirrhosis: assessment by duplex sonography. Z Gastroenterol 1993, 31:425-428.
24. Zoller WG, Zentner J, Zöllner N: Nichtinvasive Untersuchungen zur Hämodynamik der V. portae unter Propranolol. Z Gastroenterol 1990, 28:550.
25. Blei AT, Garcia-Tsao G, Groszmann RJ, et al.: Hemodynamic evaluation of isosorbide dinitrate in alcoholic cirrhosis: pharmacokinetic-hemodynamic interactions. Gastroenterology 1987, 93:576-583.
26. Garcia-Tsao G, Groszmann RJ: Portal hemodynamics during nitroglycerin administration in cirrhotic patients. Hepatology 1987, 7:805-809.
27. Kroeger RJ, Groszmann RJ: The effect of the combination of nitroglycerin and propranolol on splanchnic and systemic hemodynamics in a portal hypertensive rat model. Hepatology 1985, 5:425-430.
28. García-Pagán JC, Feu F, Bosch J, et al.: Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis. Hepatology 1990, 11:230-238.
29. García-Pagán JC, Feu F, Bosch J, et al.: Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. Ann Intern Med 1991, 114:869-873.
30. Del Arbol LR, García-Pagán JC, Feu F, et al.: Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis. J Hepatol 1991, 13:179-186.
31. Eberl T, Barnert J, Wienbeck M: Effects of molsidomine on portal hemodynamics in liver cirrhosis: a dose-dependency study. Gastroenterology 1994, 106(suppl.):A887.
32. Hüppe D, Jäger D, Tromm A, et al.: Einfluß von Molsidomin und Molsidomin + Propranolol auf die portale und kardiale Hämodynamik bei Leberzirrhose. Z Gastroenterol 1993, 31:107.
33. Vinel J-P, Monnin J-C, Combis J-M, et al.: Hemodynamic evaluation of molsidomine: a vasodilator with antianginal properties in patients with alcoholic cirrhosis. Hepatology 1990, 11:239-242.
34. Pascal J-P, Cales P, Multicenter Study Group: Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1987, 317:856-861.
35. Bosch J, Groszmann RJ, Grace N, et al.: Propranolol in the prevention of the first haemorrhage from esophageal varices: results of a randomized, double-blind, cooperative trial. J.Hepatol 1988, 7:12.
36. Idéo G, Bellati G, Fesce E, et al.: Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study. Hepatology 1988, 8:6-9.
37. Lebrec D, Poynard T, Capron J-P, et al.: Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. J Hepatol 1988, 7:118-125.
38. Strauss E, de Sá MFC, Albano A, et al.: A randomized controlled trial for the prevention of the first upper gastrointestinal bleeding due to portal hypertension in cirrhosis: sclerotherapy or propranolol versus control groups. Hepatology 1988, 8:1395.
39. The Italian Multicenter Project for Propranolol in Prevention of Bleeding: Propranolol prevents first gastrointestinal bleeding in non-ascitic cirrhotic patients. Final report of a multicenter randomized trial. J Hepatol 1989, 9:75-83.
40. Andréani T, Poupon RE, Balkau BJ, et al.: Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo. Hepatology 1990, 12:1413-1419.
41. Colman J, Jones P, Finch C, et al.: Propranolol in the prevention of variceal haemorrhage in alcoholic cirrhotic patients. Hepatology 1990, 12:851.
42. Conn HO, Grace ND, Bosch J, et al.: Propranolol in the prevention of the first haemorrhage from esophagogastric varices: a multicenter, randomized clinical trial. Hepatology 1991, 13:902-912.
43. Poynard T, Calès P, Pasta L, et al.: Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. N Engl J Med 1991, 324:1532-1538.
44. Angelico M, Carli L, Piat C, et al.: Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis. Gastroenterology 1993, 104:1460-1465.
45. Hayes PC, Davis JM, Lewis JA, et al.: Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet 1990, 336:153-156.
46. Pagliaro L, Burroughs AK, Sorensen TIA, et al.: Therapeutic controversies and randomised controlled trials (RCTs): prevention of bleeding and rebleeding in cirrhosis. Gastroenterol Internat 1989, 2:71-84.
47. Pagliaro L, Burroughs AK, Sørensen TIA, et al.: Beta-blockers for preventing variceal bleeding. Lancet 1990, 336:1001-1002.
48. Pagliaro L, D'Amico G, Sørensen TIA, et al.: Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med 1992, 117:59-70.
49. Lebrec D, Poynard T, Hillon P, et al.: Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. N Engl J Med 1981, 305:1371-1374.
50. Lebrec D, Poynard T, Bernuau J, et al.: A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology 1984, 4:355-358.
51. Burroughs AK, Jenkins WJ, Sherlock S, et al.: Controlled trial of propranolol for the prevention of recurrent variceal haemorrhage in patients with cirrhosis. N Engl J Med 1983, 309:1539-1542.
52. Uribe M, Ballesteros A, Strauss R, et al.: Use of cardioselective beta blockers in portal hypertension and advanced liver disease. Gastroenterology 1983, 84:1339.
53. Cerbelaud P, Lavignolle A, Perrin D, et al.: Propranolol et prevention des récidives de rupture de varice oesophagienne du cirrhotique. Gastroenterol Clin Biol 1986, 10:18A.
54. Villeneuve J-P, Pomier-Layrargues G, Infante-Rivard C, et al.: Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial. Hepatology 1986, 6: 1239-1243.
55. Gatta A, Merkel C, Sacerdoti D, et al.: Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial. Digestion 1987, 37:22-28.
56. Mills RP, Garden OJ, Birnie DD, et al.: Propranolol in the prevention of further variceal hemorrhage in cirrhosis. Gastroenterology 1987, 92:1755.
57. Queuniet AM, Czernichow P, Lerebours E, et al.: Etude contrôlée du propranolol dans la prévention des récidives hémorragiques chez les patients cirrhotiques. Gastroenterol Clin Biol 1987, 11:41-47.
58. Marbet UA, Straumann A, Gyr KE, et al.: Reduction in early recurrence of variceal bleeding by propranolol. Scand J Gastroenterol 1988, 23:369-374.
59. Kiire CF: Controlled trial of propranolol to prevent recurrent variceal bleeding in patients with non-cirrhotic portal fibrosis. BMJ 1989, 298:1363-1365.
60. Sheen IS, Chen TY, Liaw YF: Randomized controlled study of propranolol for prevention of recurrent esophageal varices bleeding in patients with cirrhosis. Liver 1989, 9:1-5.
61. Garden OJ, Mills PR, Birnie GG, et al.: Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial. Gastroenterology 1990, 98:185-190.
62. Rossi V, Calès P, Burtin P, et al.: Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy. J Hepatol 1991, 12:283-289.
63. Westaby D, Melia W, Hegarty J, et al.: Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration. Hepatology 1986, 6:673-675.
64. Fleig WE, Stange EF, Hunecke R, et al.: Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy. Hepatology 1987, 7:355-361.
65. Alexandrino PT, Alves MM, Correia JP: Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal bleeding. J Hepatol 1988, 7:175-185.
66. Dollet JM, Champigneulle B, Patris A, et al.: Sclérotherapie endoscopique contre propranolol après hémorragie par rupture de varices oesophagiennes chez le cirrhotique. Résultats à 4 ans d'une étude randomisée. Gastroenterol Clin Biol 1988, 12:234-239.
67. Westaby D, Polson RJ, Gimson AES, et al.: A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding. Hepatology 1990, 11:353-359.
68. Andréani T, Poupon RE, Balkau B, et al.: Efficacité comparée du propranolol et des scleroses endoscopiques de varices oesophagiennes dans la prevention des récidives d'hémorragies digestives au cours des cirrhoses. Etude contrôlée. Gastroenterol Clin Biol 1991, 15(suppl. 2):A215.
69. Martin T, Taupignon A, Lavignolle A, et al.: Prévention des récidives hémorragiques chez des malades atteints de cirrhose. Gastroenterol Clin Biol 1991, 15:833-837.
70. Dasarathy S, Dwivedi M, Bhargava DK, et al.: A prospective randomized trial comparing repeated endoscopic sclerotherapy and propranolol in decompensated (Child Class B and C) cirrhotic patients. Hepatology 1992, 16:89-94.
71. Dwivedi M, Bhargava DK, Ramachandran K: Endoscopic sclerotherapy versus propranolol in prevention of recurrent variceal bleeding in patients with Child's B and C cirrhosis: A preliminary report. Indian J Gastroenterol 1992, 11:68-70.
72. Terés J, Bosch J, Bordas JM, et al.: Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial. Gastroenterology 1993, 105:1508-1514.
73. Acharya SK, Dasarathy S, Saksena S, et al.: A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy. J Hepatol 1993, 19:291-300.
74. Avgerinos A, Rekoumis C, Klonis C, et al.: Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial. J Hepatol 1993, 19:301-311.
75. Jensen LS, Krarup N: Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy. Scand J Gastroenterol 1989, 24:339-345.
76. Jensen LS, Krarup N: Propranolol may prevent recurrence of oesophageal varices after obliteration by endoscopic sclerotherapy. Scand J Gastroenterol 1990, 25:352-356.
77. Vickers C, Rhodes J, Hillenbrand P, et al.: Prospective controlled trial of propranolol and sclerotherapy for prevention of rebleeding from oesophageal varices. Gut 1987, 28:A1359.
78. Vinel J-P, Lamouliatte H, Cales P, et al.: Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration. Gastroenterology 1992, 102: 1760-1763.
79. Lo G-H, Lai K-H, Lee S-D, et al.: Does propranolol maintain post-sclerotherapy variceal obliteration? A prospective randomized study. J Gastroenterol Hepatol 1993, 8:358-362.
80. Ink O, Martin T, Poynard T, et al.: Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial. Hepatology 1992, 16:912-919
81. Merkel C, Morabito A: Adding beta-blockers to sclerotherapy in the prevention of variceal rebleeding: a meta-analysis assessment. J Hepatol 1994, 21:918-919.
82. Hosking SW, Kennedy HJ, Seddon I, et al.: The role of propranolol in congestive gastropathy of portal hypertension. Hepatology 1987, 7:437-441.
83. Pérez-Ayuso RM, Piqué JM, Bosch J, et al.: Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 1991, 337:1431-1434.
84. Dumas O, Boustière C, Letard JC, et al.: Effect of endoscopic injection sclerotherapy on gastric varices and portal hypertensive gastropathy: endoscopic ultrasonography data. Gastroenterology 1994, 106(suppl.): A886.
85. The Veterans Affairs Cooperative Variceal Sclerotherapy Group: Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. N Engl J Med 1991, 324:1779-1784.
86. Van Ruiswyk J, Byrd JC: Efficacy of prophylactic sclerotherapy for prevention of a first variceal hemorrhage. Gastroenterology 1992, 102:587-597.
87. Fardy JM, Laupacis A: A meta-analysis of prophylactic endoscopic sclerotherapy for esophageal varices. Am J Gastroenterol 1994, 89:1938-1948.
88. Calès P, and the Study Group of Primary Prophylaxis: Factors associated with failure of propranolol for the prevention of first bleeding in cirrhotic patients. Gastroenterol Clin Biol 1992, 16:504-510.
89. Kleber C, Sauerbruch T, Ansari H, et al.: Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study. Gastroenterology 1991, 100:1332-1337.
90. Merkel C, Bolognesi M, Bellon S, et al.: Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology 1992, 102:973-979.
91. Pugh S, Lewis S, Smith PM: Bleeding oesophageal varices in alcoholic cirrhosis: long-term follow-up of endoscopic sclerotherapy. QJM 1993, 86:241-245.
92. Staritz M: Esophageal endoscopy for the assessment of risk of hemorrhage of esophageal hemorrhage. Z Gastroenterol 1990, 28:405-407.
93. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices: Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1988, 319:983-989.
94. Zoller WG, Zöllner N: Wirkungen von Propranolol auf die Hämodynamik der Pfortader bei Patienten mit Leberzirrhose. Klin Wochenschr 1991, 69(suppl XII):90.
95. Infante-Rivard C, Esnaola S, Villeneuve J-P: Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: a meta-analysis. Gastroenterology 1989, 96:1087-1092.